GlassScriptPhysician profile
Frank J White
NPI 1376512970
$2,799.99
in general payments reported to CMS, 2019-2025
29 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $241 · 2021: $576 · 2022: $648 · 2023: $518 · 2024: $112 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $598.51 | 2019-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $344.02 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $233.93 | 2019-2022 | |
| Evofem Biosciences, INC. | $197.74 | 2020-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $177.91 | 2021-2025 | |
| Coopersurgical, INC. | $129.86 | 2019-2025 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $113.56 | 2020-2022 | |
| Organon LLC | $102.72 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $96.13 | 2022-2025 | Veozah |
| Agile Therapeutics, INC. | $91.76 | 2021-2022 | |
| Myovant Sciences INC. | $70.36 | 2021-2022 | |
| Avion Pharmaceuticals | $69.51 | 2020-2022 | |
| Amgen INC. | $66.54 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $63.24 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $62.63 | 2024-2025 | Aptima, Thinprep 2000 Processor |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $59.46 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.67 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $44.57 | 2022 | |
| Dysis Medical, INC. | $32.34 | 2019-2022 | |
| Allergan, INC. | $28.99 | 2019 | |
| Roche Diagnostics Corporation | $24.76 | 2020 | |
| Daiichi Sankyo INC. | $23.27 | 2023 | Injectafer |
| Baxter Healthcare | $20.71 | 2019 | |
| Exact Sciences Corporation | $20.27 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $17.12 | 2023 | |
| Vertical Pharmaceuticals, LLC | $16.90 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.97 | 2019 | |
| Shield Therapeutics INC | $14.07 | 2025 | |
| Minerva Surgical, INC | $13.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.